Global Varicella Zoster Infection Treatment Market : 2019-2027

The Global Varicella Zoster Infection Treatment Market value is projected to reach US$ 1.99 Bn. at the end of the forecast period and it is expected to grow at the CAGR of 4.12%. Varicella-zoster virus belongs to α- herpes virus family which is known to infect humans. This virus is present worldwide and is highly infectious. The primary infection causes acute varicella or chickenpox, which commonly affects children, teens, and young adults. The infection is transmitted through direct contact with a skin lesions or through respiratory droplets. After initial infection, this virus establishes lifelong latency in cranial nerve and dorsal root ganglia and can reactivate years later as Herpes zoster or shingles.

Global Varicella Zoster Infection Treatment Market overview:-

The Global Varicella Zoster Treatment Market is anticipated to grow during the forecast period owing to the key factors such as rising geriatric population, the prevalence of chickenpox and similar diseases. Growing numbers of drugs producing companies along with emerging technologies are expected to create potential opportunities for Varicella Zoster Infection Market. However, a stringent regulatory approval process may hamper the growth of the market. Along with this, many people rely on alternative medicines made from natural products, which are expected to hamper the antiviral drugs market. Unawareness about Herpes zoster among people in many regions across the globe may also restraint the growth of the market.

Scope of the Global Varicella Zoster Infection Treatment Market : Inquire before buying

Global Varicella Zoster Infection Treatment Market

Global Varicella Zoster Infection Treatment Market Segment overview:-

Global Varicella Zoster Infection Treatment Market1 To know about the Research Methodology :- Request Free Sample Report By the Drug Type segment, the largest market share is held by Acyclovir as numerous companies manufacture it on large scale. Pricing for this drug is comparatively cheap, hence many physicians prescribe it for the treatment of Varicella Zoster infection. It is expected that acyclovir will hold the largest revenue during the forecast period.

Global Varicella Zoster Infection Treatment Market Regional Insights:-

Global Varicella Zoster Infection Treatment Market2 The largest share of the Global Varicella-Zoster Treatment Market is held by North America. More than 90% of adults in the United States acquired the disease in childhood, while the majority of children and young adults have been vaccinated with the live virus vaccine.

Key players operating in Varicella Zoster Infection market:

• Dr. Reddy’s Laboratories Ltd. • Pfizer Inc. • Abbott Laboratories • Teva Pharmaceutical Industries Ltd. • Mylan N.V. • Sun Pharmaceuticals • Valeant pharmaceuticals • Novartis AG • GlaxoSmithKline Plc. • Bausch health • Merck Sharp & Dohme corp. The objective of the report is to present a comprehensive analysis of the Global Varicella Zoster Infection Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Varicella Zoster Infection Treatment Market dynamics, structure by analyzing the market segments and project the Global Varicella Zoster Infection Treatment Marketsize. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Varicella Zoster Infection Treatment Market make the report investor’s guide.

Global Varicella Zoster Infection Treatment Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Varicella Zoster Infection Treatment Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Varicella Zoster Infection Treatment Market Analysis and Forecast 6.1. Varicella Zoster Infection Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Varicella Zoster Infection Treatment Market Analysis and Forecast, By Drug Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 7.4. Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast, By Drug Type 7.5. Varicella Zoster Infection Treatment Market Analysis, By Drug Type 7.6. Varicella Zoster Infection Treatment Market Attractiveness Analysis, By Drug Type 8. Global Varicella Zoster Infection Treatment Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Varicella Zoster Infection Treatment Market Value Share Analysis, By Brake Used 8.4. Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast, By Brake Used 8.5. Varicella Zoster Infection Treatment Market Analysis, By Brake Used 8.6. Varicella Zoster Infection Treatment Market Attractiveness Analysis, By Brake Used 9. Global Varicella Zoster Infection Treatment Market Analysis, by Region 9.1. Varicella Zoster Infection Treatment Market Value Share Analysis, by Region 9.2. Varicella Zoster Infection Treatment Market Size (US$ Mn) Forecast, by Region 9.3. Varicella Zoster Infection Treatment Market Attractiveness Analysis, by Region 10. North America Varicella Zoster Infection Treatment Market Analysis 10.1. Key Findings 10.2. North America Varicella Zoster Infection Treatment Market Overview 10.3. North America Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 10.4. North America Varicella Zoster Infection Treatment Market Forecast, By Drug Type 10.4.1. Acyclovir 10.4.2. Valacyclovir 10.4.3. Famciclovir 10.5. North America Varicella Zoster Infection Treatment Market Value Share Analysis, By Route of Administration 10.6. North America Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 10.6.1. oral 10.6.2. Topical 10.6.3. Injectable 10.7. North America Varicella Zoster Infection Treatment Market Value Share Analysis, by Country 10.8. North America Varicella Zoster Infection Treatment Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America Varicella Zoster Infection Treatment Market Analysis, by Country 10.10. U.S. Varicella Zoster Infection Treatment Market Forecast, By Drug Type 10.10.1. Acyclovir 10.10.2. Valacyclovir 10.10.3. Famciclovir 10.11. U.S. Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 10.11.1. oral 10.11.2. Topical 10.11.3. Injectable 10.12. Canada Varicella Zoster Infection Treatment Market Forecast, By Drug Type 10.12.1. Acyclovir 10.12.2. Valacyclovir 10.12.3. Famciclovir 10.13. Canada Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 10.13.1. oral 10.13.2. Topical 10.13.3. Injectable 10.14. Mexico Varicella Zoster Infection Treatment Market Forecast, By Drug Type 10.14.1. Acyclovir 10.14.2. Valacyclovir 10.14.3. Famciclovir 10.15. Mexico Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 10.15.1. oral 10.15.2. Topical 10.15.3. Injectable 10.16. North America Varicella Zoster Infection Treatment Market Attractiveness Analysis 10.16.1. By Drug Type 10.16.2. By Route of Administration 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe Varicella Zoster Infection Treatment Market Analysis 11.1. Key Findings 11.2. Europe Varicella Zoster Infection Treatment Market Overview 11.3. Europe Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 11.4. Europe Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.4.1. Acyclovir 11.4.2. Valacyclovir 11.4.3. Famciclovir 11.5. Europe Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.5.1. oral 11.5.2. Topical 11.5.3. Injectable 11.6. Europe Varicella Zoster Infection Treatment Market Value Share Analysis, by Country 11.7. Europe Varicella Zoster Infection Treatment Market Forecast, by Country 11.7.1. Germany 11.7.2. U.K. 11.7.3. France 11.7.4. Italy 11.7.5. Spain 11.7.6. Sweden 11.7.7. CIS countries 11.7.8. Rest of Europe 11.8. Germany Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.8.1. Acyclovir 11.8.2. Valacyclovir 11.8.3. Famciclovir 11.9. Germany Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.9.1. oral 11.9.2. Topical 11.9.3. Injectable 11.10. U.K. Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.10.1. Acyclovir 11.10.2. Valacyclovir 11.10.3. Famciclovir 11.11. U.K. Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.11.1. oral 11.11.2. Topical 11.11.3. Injectable 11.12. France Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.12.1. Acyclovir 11.12.2. Valacyclovir 11.12.3. Famciclovir 11.13. France Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.13.1. oral 11.13.2. Topical 11.13.3. Injectable 11.14. Italy Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.14.1. Acyclovir 11.14.2. Valacyclovir 11.14.3. Famciclovir 11.15. Italy Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.15.1. oral 11.15.2. Topical 11.15.3. Injectable 11.16. Spain Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.16.1. Acyclovir 11.16.2. Valacyclovir 11.16.3. Famciclovir 11.17. Spain Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.17.1. oral 11.17.2. Topical 11.17.3. Injectable 11.18. Sweden Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.18.1. Acyclovir 11.18.2. Valacyclovir 11.18.3. Famciclovir 11.19. Sweden Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.19.1. oral 11.19.2. Topical 11.19.3. Injectable 11.20. CIS countries Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.20.1. Acyclovir 11.20.2. Valacyclovir 11.20.3. Famciclovir 11.21. CIS countries Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.21.1. oral 11.21.2. Topical 11.21.3. Injectable 11.22. Rest of Europe Varicella Zoster Infection Treatment Market Forecast, By Drug Type 11.22.1. Acyclovir 11.22.2. Valacyclovir 11.22.3. Famciclovir 11.23. Rest of Europe Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 11.23.1. oral 11.23.2. Topical 11.23.3. Injectable 11.24. Europe Varicella Zoster Infection Treatment Market Attractiveness Analysis 11.24.1. By Route of Administration 11.24.2. By Drug Type 11.25. PEST Analysis 11.26. Key Trends 11.27. Key Developments 12. Asia Pacific Varicella Zoster Infection Treatment Market Analysis 12.1. Key Findings 12.2. Asia Pacific Varicella Zoster Infection Treatment Market Overview 12.3. Asia Pacific Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 12.4. Asia Pacific Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.4.1. Acyclovir 12.4.2. Valacyclovir 12.4.3. Famciclovir 12.5. Asia Pacific Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 12.6. Asia Pacific Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.6.1. oral 12.6.2. Topical 12.6.3. Injectable 12.7. Asia Pacific Varicella Zoster Infection Treatment Market Value Share Analysis, by Country 12.8. Asia Pacific Varicella Zoster Infection Treatment Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. South Korea 12.8.5. Australia 12.8.6. ASEAN 12.8.7. Rest of Asia Pacific 12.9. Asia Pacific Varicella Zoster Infection Treatment Market Analysis, by Country 12.10. China Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.10.1. Acyclovir 12.10.2. Valacyclovir 12.10.3. Famciclovir 12.11. China Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.11.1. oral 12.11.2. Topical 12.11.3. Injectable 12.12. India Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.12.1. Acyclovir 12.12.2. Valacyclovir 12.12.3. Famciclovir 12.13. India Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.13.1. oral 12.13.2. Topical 12.13.3. Injectable 12.14. Japan Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.14.1. Acyclovir 12.14.2. Valacyclovir 12.14.3. Famciclovir 12.15. Japan Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.15.1. oral 12.15.2. Topical 12.15.3. Injectable 12.16. South Korea Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.16.1. Acyclovir 12.16.2. Valacyclovir 12.16.3. Famciclovir 12.17. South Korea Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.17.1. oral 12.17.2. Topical 12.17.3. Injectable 12.18. Australia Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.18.1. Acyclovir 12.18.2. Valacyclovir 12.18.3. Famciclovir 12.19. Australia Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.19.1. oral 12.19.2. Topical 12.19.3. Injectable 12.20. ASEAN Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.20.1. Acyclovir 12.20.2. Valacyclovir 12.20.3. Famciclovir 12.21. ASEAN Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.21.1. oral 12.21.2. Topical 12.21.3. Injectable 12.22. Rest of Asia Pacific Varicella Zoster Infection Treatment Market Forecast, By Drug Type 12.22.1. Acyclovir 12.22.2. Valacyclovir 12.22.3. Famciclovir 12.23. Rest of Asia Pacific Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 12.23.1. oral 12.23.2. Topical 12.23.3. Injectable 12.24. Asia Pacific Varicella Zoster Infection Treatment Market Attractiveness Analysis 12.24.1. By Drug Type 12.24.2. By Route of Administration 12.25. PEST Analysis 12.26. Key Trends 12.27. Key Developments 13. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Varicella Zoster Infection Treatment Market Overview 13.3. Middle East & Africa Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 13.4. Middle East & Africa Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.4.1. Acyclovir 13.4.2. Valacyclovir 13.4.3. Famciclovir 13.5. Middle East & Africa Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.5.1. oral 13.5.2. Topical 13.5.3. Injectable 13.6. Middle East & Africa Varicella Zoster Infection Treatment Market Value Share Analysis, by Country 13.7. Middle East & Africa Varicella Zoster Infection Treatment Market Forecast, by Country 13.7.1. GCC Countries 13.7.2. South Africa 13.7.3. Nigeria 13.7.4. Egypt 13.7.5. Rest of Middle East & Africa 13.8. Middle East & Africa Varicella Zoster Infection Treatment Market Analysis, by Country 13.9. GCC Countries Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.9.1. Acyclovir 13.9.2. Valacyclovir 13.9.3. Famciclovir 13.10. GCC Countries Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.10.1. oral 13.10.2. Topical 13.10.3. Injectable 13.11. South Africa Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.11.1. Acyclovir 13.11.2. Valacyclovir 13.11.3. Famciclovir 13.12. South Africa Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.12.1. oral 13.12.2. Topical 13.12.3. Injectable 13.13. Nigeria Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.13.1. Acyclovir 13.13.2. Valacyclovir 13.13.3. Famciclovir 13.14. Nigeria Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.14.1. oral 13.14.2. Topical 13.14.3. Injectable 13.15. Egypt Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.15.1. Acyclovir 13.15.2. Valacyclovir 13.15.3. Famciclovir 13.16. Egypt Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.16.1. oral 13.16.2. Topical 13.16.3. Injectable 13.17. Rest of Middle East & Africa Varicella Zoster Infection Treatment Market Forecast, By Drug Type 13.17.1. Acyclovir 13.17.2. Valacyclovir 13.17.3. Famciclovir 13.18. Rest of Middle East & Africa Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 13.18.1. oral 13.18.2. Topical 13.18.3. Injectable 13.19. Middle East & Africa Varicella Zoster Infection Treatment Market Attractiveness Analysis 13.19.1. By Drug Type 13.19.2. By Route of Administration 13.20. PEST Analysis 13.21. Key Trends 13.22. Key Developments 14. South America Varicella Zoster Infection Treatment Market Analysis 14.1. Key Findings 14.2. South America Varicella Zoster Infection Treatment Market Overview 14.3. South America Varicella Zoster Infection Treatment Market Value Share Analysis, By Drug Type 14.4. South America Varicella Zoster Infection Treatment Market Forecast, By Drug Type 14.4.1. Acyclovir 14.4.2. Valacyclovir 14.4.3. Famciclovir 14.5. South America Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 14.5.1. oral 14.5.2. Topical 14.5.3. Injectable 14.6. South America Varicella Zoster Infection Treatment Market Value Share Analysis, by Country 14.7. South America Varicella Zoster Infection Treatment Market Forecast, by Country 14.7.1. Brazil 14.7.2. Colombia 14.7.3. Argentina 14.7.4. Rest of South America 14.8. South America Varicella Zoster Infection Treatment Market Analysis, by Country 14.9. Brazil Varicella Zoster Infection Treatment Market Forecast, By Drug Type 14.9.1. Acyclovir 14.9.2. Valacyclovir 14.9.3. Famciclovir 14.10. Brazil Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 14.10.1. oral 14.10.2. Topical 14.10.3. Injectable 14.11. Colombia Varicella Zoster Infection Treatment Market Forecast, By Drug Type 14.11.1. Acyclovir 14.11.2. Valacyclovir 14.11.3. Famciclovir 14.12. Colombia Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 14.12.1. oral 14.12.2. Topical 14.12.3. Injectable 14.13. Argentina Varicella Zoster Infection Treatment Market Forecast, By Drug Type 14.13.1. Acyclovir 14.13.2. Valacyclovir 14.13.3. Famciclovir 14.14. Argentina Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 14.14.1. oral 14.14.2. Topical 14.14.3. Injectable 14.15. Rest of South America Varicella Zoster Infection Treatment Market Forecast, By Drug Type 14.15.1. Acyclovir 14.15.2. Valacyclovir 14.15.3. Famciclovir 14.16. Rest of South America Varicella Zoster Infection Treatment Market Forecast, By Route of Administration 14.16.1. oral 14.16.2. Topical 14.16.3. Injectable 14.17. South America Varicella Zoster Infection Treatment Market Attractiveness Analysis 14.17.1. By Drug Type 14.17.2. By Route of Administration 14.18. PEST Analysis 14.19. Key Trends 14.20. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Dr. Reddy’s Laboratories Ltd. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Pfizer Inc. 15.3.3. Abbott Laboratories 15.3.4. Teva Pharmaceutical Industries Ltd. 15.3.5. Mylan N.V. 15.3.6. Sun Pharmaceuticals 15.3.7. Valeant pharmaceuticals 15.3.8. Novartis AG 15.3.9. GlaxoSmithKline Plc. 15.3.10. Bausch health 15.3.11. Merck Sharp & Dohme corp. 16. Primary key Insights

About This Report

Report ID 81452
Category Healthcare
Published Date January 2021
Updated Date Oct 2021
Contact Us